Literature DB >> 6174093

Myocardial flow distribution. II : Empty beating heart, ventricular fibrillation and cardiac arrest.

S M Mosca, E Escudero, R J Gelpi, A T Kosoglov, G J Rinaldi, H E Cingolani.   

Abstract

Myocardial oxygen consumption (MVO2) and coronary blood flow (CBF) distribution were studied in 21 isolated, metabolically supported dog hearts. Measurements of MVO2 and CBF distribution were carried out in three different experimental conditions : empty beating heart (EBH), ventricular fibrillation (VF) and high potassium-induced cardiac arrest (CA). MVO2 was approximately the same in EBH and VF (4.09 +/- 0.77 and 4.28 +/- 0.68 ml O2 min-1 100 g-1 respectively), and significantly lower in the group with CA (2.40 +/- 0.18 ml O2 min-1 100 g-1, P less than 0.05). Total CBF showed no significant differences among the three groups (84 +/- 7 ml/min in EBH; 78 +/- 7 ml/min in VF and 83 +/- 7 ml/min in CA). Subendocardial CBF per unit of tissue mass was significantly lower in hearts with VF (0.43 +/- 0.01 ml/min-1 g-1, P less than 0.05) when tested against the other two groups of experiments (0.69 +/- 0.03 ml min-1 g-1 in EBH and 0.65 +/- +/- 0.04 ml min-1 g-1 in CA). This was also reflected in the endo/epi ratio, that was significantly lower in VF (1.41 +/- 0.07, P less than 0.05) with respect to the other two groups (2 +/- 0.09 in EBH and 2.21 +/- 0.07 in CA). From data presented here we can conclude that cardioplegia, even in absence of hypothermia, is a method that will assure myocardial protection providing : (1) a lower subendocardial MVO2; (2) a higher subendocardial CBF, which helps for a prompt recovery during reperfusion.

Entities:  

Mesh:

Year:  1981        PMID: 6174093     DOI: 10.3109/13813458109069485

Source DB:  PubMed          Journal:  Arch Int Physiol Biochim        ISSN: 0003-9799


  1 in total

1.  Perfluorocarbon induced intra-arrest hypothermia does not improve survival in a swine model of asphyxial cardiac arrest.

Authors:  Ali S Albaghdadi; Leonard A Brooks; Andrew M Pretorius; Richard E Kerber
Journal:  Resuscitation       Date:  2009-12-31       Impact factor: 5.262

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.